Venetoclax triggers sub-lethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
Caroline A. Heckman(University of Helsinki), Krister Wennerberg(University of Helsinki)
Cited by 1
Related Papers
Rho-family GTPases: it's not only Rac and Rho (and I like it)
|Journal of Cell Science|2004|594
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
|Haematologica|2019|184
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML
|Blood|2017|122
The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis
|Cancer Research|2008|117
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
|Developmental Cell|2023|112